At each and every step of your workflow, we want to be able to disrupt and dismantle SARS-CoV-2. This means understanding its entry points into host cells and the pathways it utilizes. It means discerning effective cellular responses in COVID-19 patients and disease models. And it means discovering new biomarkers and pathways for therapeutic treatments, vaccine candidates, and viral detection kits. We've organized our diverse products (antibodies, recombinant proteins, cytokine detection kits, and proteogenomics profiling options) by workflow stages, making it easier to pick your reagents and start your experiments. In addition, we offer a blog and video library with informative content on COVID-19.
BioLegend wants to help in your fight against COVID-19
As noted on our COVID-19 Statement Webpage, BioLegend is here to collaborate with your organization to help you accelerate the development of diagnostic tests, therapeutics, and vaccines for SARS-CoV-2. Please reach out if you require a custom reagent or would like to tell us how we can support your work. Together, we can find a solution.
Viral entry and the resulting inflammation are key mechanisms under investigation by SARS-CoV-2 researchers. We provide SARS-CoV-2 recombinant proteins and antibodies to investigate the interactions between S1 spike protein and human ACE2 for viral entry. Our 
Once you’ve studied the entry points and how SARS-CoV-2 attacks cells, you’re ready to shift your focus onto the immune cell response. In order to gauge an effective immune response, it is critical to characterize the cellular immune response, particularly T cells. We have developed unique tools: MojoSort™ kits for the isolation of desired populations; MHC monomers pre-loaded with SARS-CoV-2 peptides for antigen-specific T cell studies; and antibodies to detect key components of anti-viral pathways. BioLegend provides key tools for discovering how cells work together to dismantle
